Great that we'll (hopefully) soon be able to look at those minutes. I wonder if they will reveal anything about the changes to the recovery criteria. If they don't, that will be big news in itself. What's not discussed in the minutes may be as interesting as what is.
Some quick notes on the judgement - was a bit of a roller-coaster to read imo. 
Another reminder to everyone that if ever feeling frustrated and angry about something, before hitting 'post reply' it's worth thinking about whether it could be used by QMUL to try to present PACE critics as unreasonable (QMUL actually focussed on a PR thread where I was by far the most militant so do as I say, not as I do... *grumble* *grumble* I had good reason for being pissed off). They also seemed to be trying to use criticism of the ICO and any Tribunal judgemenets against us... sorry ICOers but sometimes you get things wrong. This time the ICO found that the disparaging comments were not serious enough to affect their judgement, it's always possible that another officer could decide differently:
"In   particular   the   university  provided   a   link   to   a   discussion   on   that   forum   which   commented   on   the  Tribunal's   decision   to   uphold   the   refusal   of   the   earlier   request   for   these  minutes.   Many   of   the   comments   are   disparaging   of   both   the   judgement  and   the   research   itself.   The   Commissioner   considers   that   although  anyone   unaccustomed   to   facing   a   disgruntled   audience   is   likely   to   find  some   of   the   comments   unpleasant,   the   dissatisfaction   is   not   expressed  in   such   strong   terms   that   it   would   cause   those   against   who   it   is   directed  at   any   real   concern."
There were some annoying bits in the judgement, where it really seemed that the ICO had just gone with QMUL's narrative, then there were other bits which I thought strongly stood up to arguments from QMUL that I thought might be more persuasive. There are a lot of complicated issues related to PACE, and I'm not sure how much we should expect an officer at the ICO to properly understand them all.
I think that presenting this as a divide over whether CFS should be viewed and treated as a physical or psychiatric condition is a real distraction from the central issue of the quality of the PACE trial as a piece of research, and the danger of it's purported results misleading doctors and patients. I realise that this is a difficult topic to summarise but I felt like the ICO summary really promoted QMUL's narrative on this (although I've not seen Peter's submissions, so maybe he agreed with it, in which case I can't blame the ICO for going with it):
	
	
		
		
			The  causes,  and  therefore  the  treatment,  of  chronic  fatigue  syndrome  is a  contentious  area  of  science.  The  Commissioner  understands  that  there are  those  who  believe  it  has  a  physical  cause  and  therefore  should  be treated  as such,  while  another  school  of  thought  approaches  its treatment  from  a  psychiatric  perspective.  The  two  treatments  found  by the  trial  to  be  most  effective  are  psychiatric  therapies.  Some  patients and  patient  groups  maintain  that  by  ignoring  the  physical  cause  of  the condition,  these  two  therapies  can  result  in  patients  suffering  adverse effects.  The  rigour  of  the  methodology  employed  in  the  trial and  its results  were  therefore  challenged,  the   validity  of  those  challenges  is debated  as  is  the  extent  to  which  trial's  findings  are  generally  accepted within  the  scientific  and  medical  community.  It  is  fair to  say  however that  the  trial  attracted  some  controversy.
		
		
	 
Actually, I may have been a bit unfair on the ICO on my first reading, as when I went to find others bit like that which had annoyed me, it was the ICO giving QMUL's opinion, not their own: "This   is   based   on   the   university's  belief   that   there   exists   a   group   of   patient   activists   who   feel   so   strongly  that   research   into   chronic   fatigue   syndrome   should   focus   solely   on   it  being   a   physical   illness   that   they   would   seek   to   discredit   any   work   which  takes   a   psychiatric   approach."
(18) "The   treatment   of   chronic   fatigue  syndrome   is   a   contentious   area   of   science   and   the   university   considers  that   those   involved   in   this   area   of   work   have   concerns   that   they   could  become   the   target   of   adverse   criticism   in   the   event   their   research   was  not   accepted   by   those   who   favour   the   condition   being   treated   purely   as  a   physical   illness."
There were still parts that made me think that the ICO officer had quite different values to myself, eg (31): "However  she  has  found  no  reason  to  question  the  integrity  of the  researchers  or  those  involved  in  the  steering  committee." I think that everyone's integrity should be questioned, particularly if they hold positions of power or authority. I'm not sure if she had the problems with PACE's recovery claims explained to her, but it's pretty difficult to understand them and not think that someone has acted with less than impressive integrity.
The judgement made me think that need to remember that word of the replication crisis, and other problems in academic research, might not have spread to the ICO. Some parts of this judgement seemed founded in some slightly old fashioned ideas about academia. I need to remember that most people in the UK will not be aware of a lot of the issues we spend a lot of time discussing.
Paragraph 17 is of interest for stating that the Principal for QMUL was familiar with the issues surrounding PACE. There's a lot from this person, and it really seems to indicate that the QMUL administration are not doing their jobs properly.
In paragraph 24: "The  university  has  argued  that  the  criticism  is  unmerited  and  that the  trial  is  not  controversial  among  the  majority  of  scientists  in  the  field, or  indeed  experts  in  clinical  trials." Wow. I think this is really damaging for those at the top of QMUL. They've committed themselves to defending PACE, but it's clear that key claims from the PACE researchers are indefensible. I was thinking that they must have realised by now that they should be trying to find a way to retreat on this topic, but even their new Principal is now completely committed.
It's a real shame to lose information relating to the patient representative body.
QMUL makes use of that spun BMJ Hawkes piece, and it seems to impress the ICO somewhat. I think it could be time to focus on trying to get some of the problems with that corrected. There are a few problems at the BMJ, and they don't seem keen on correcting any of them. It will be interesting to see what happens about SMILE not being prospectively registered.